key: cord-0982754-umwwoz72
authors: Karcioglu Batur, Lutfiye; Hekim, Nezih
title: Correlation between interleukin gene polymorphisms and current prevalence and mortality rates due to novel coronavirus disease 2019 (COVID‐2019) in 23 countries
date: 2021-06-10
journal: J Med Virol
DOI: 10.1002/jmv.27127
sha: b6a0cbafa02f3adb1726b68d20fbf2721fb93324
doc_id: 982754
cord_uid: umwwoz72

BACKGROUND: The novel coronavirus disease 2019 (COVID‐19) infection may rely on a potential genetic background for the variations in the inflammatory response. We aimed to investigate the possible correlation between polymorphisms in the IL‐6 gene at rs1800796/rs1800795, in IL‐6R at rs2228145, in IL‐10 at rs1800896 and rs1800871, in IL‐17 at rs2275913 and rs763780 loci, and COVID‐19 prevalence and mortality rates among populations of 23 countries. METHODS: We searched the literature for polymorphisms in China, Japan, India, Spain, Mexico, Sweden, Turkey, Brazil, Russia, Poland, Italy, South Africa, Netherlands, Greece, Germany, UK, Iran, Finland, Czechia, Tunisia, Norway, Egypt, Croatia. We recorded the prevalence and mortality rates (per million) caused by the Coronavirus infection recorded on 7th September 2020 and 6th December 2020. RESULTS: There was a significant positive correlation between the frequency of AG genotype of rs1800896 and prevalence recorded on 6th December 2020 (r: 0.53, r (2): 0.28, p < .05). There was a significant negative correlation between the mortality rates recorded on 7th September, and the AG genotype of rs2275913 (r: −0.51, r (2): 0.26, p < .05). There was a significant positive correlation between the prevalence recorded on 6th December, and TT genotype at rs763780 (r: 0.65, r(2):0.42, p < .05) while a negative correlation between prevalence and TC genotype at rs763780 (r: −0.66, r (2): 0.43, p < .05). Also, a significant negative correlation was found between mortality rates recorded on 6th December 2020 and CC genotype at rs763780 (r: −0.56, r (2): 0.31, p < .05). CONCLUSION: The variations in prevalence of COVID‐19 and its mortality rates among countries may be explained by the polymorphisms at rs1800896 in IL‐10, rs2275913 in IL‐17A, and rs763780 loci in the IL‐17F gene.

Beginning from December 2019, the coronavirus disease 2019 , caused by severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2), has evolved into a pandemic and has given rise to challenging health concerns worldwide. 1 The pathogenesis of COVID-19 harbors an effective inflammatory response, triggering a complex group of mediators including interleukins. 3 In the course of the disease, excessive production of pro-inflammatory cytokines results in a cytokine storm which is responsible for the severe progression of the disease and the acute organ injuries. 1 The underlying mechanism is that SARS-CoV-2 can rapidly activate pathogenic T helper cell type 1 (Th1) cells to secrete pro-inflammatory cytokines including interleukin-6 (IL-6), IL-10, and IL-17. 4 COVID-19 patients were reported to have high IL-6 and IL-10 levels and low CD4 + T and CD8 + T cell levels associated with the disease severity. 5 Some studies have also reported that the patients with severe COVID-19 have higher levels of IL-2, IL-6, IL-7, IL-10 than patients with mild and moderate infections. [3] [4] [5] IL-17 levels were found to be increased in COVID-19 patients hospitalized in the intensive-care unit compared to the control patients. 6 Therefore, these key inflammatory factors in COVID- 19 have paramount importance in understanding the cytokine storm-related mortality in severe cases. 3 Genetic polymorphisms implicated in understanding the basis of diseases also allow for the prevention of the spread of infections, and for the development of potentially effective treatments against the diseases. One common type of these polymorphisms, the single nucleotide polymorphisms (SNPs) are known to be effective in the pathways that play an important role in the attachment of the microbiological agent to the host cell, in the host's resistance to the diseases, in the susceptibility to disease and the severity of diseases. 1 There are growing numbers of reports stating that severe symptoms of COVID-19 might be attributed to the human genetic variants in genes related to immune deficiency, pneumonia, sepsis, and/or cytokine storm. 7 Recently, it was reported that the G allele of the rs1800795 locus in the IL6 gene could act as a protective factor while the A allele of rs1800896 in IL10 gene could act as a risk indicator in pneumonia-induced sepsis in Chinese Han patients. In addition, these polymorphisms in IL6 gene were associated with the clinical stage of sepsis and have crucial effects on the secretion of IL-6 and IL-10 in the patients. 8 On the other hand, a report of IL-17 gene polymorphisms in patients with an acute respiratory distress syndrome (ARDS) revealed that 30-day survival rate increased in the patients with a genetic polymorphism that resulted in an attenuated IL-17 production, whereas a polymorphism that resulted in the production of more IL-17 correlated with the decreased survival rate. 9 Therefore, we hypothesized that SNPs in IL-6, IL-6R, IL-10,   IL-17A, and IL-17F genes may participate in the clinical course of   COVID-19 infection and the survival/mortality rates due to this infection.

The main goal of this study was to evaluate a possible correlation between the common polymorphisms at rs1800796/rs1800795 locus of IL-6 gene, at rs2228145 locus of IL-6R gene, at rs1800896 and rs1800871 loci of IL-10 gene, at rs2275913 locus of IL-17A gene and rs763780 locus of IL-17F gene, and the prevalence of COVID-19 and the mortality rates among populations of 23 countries including Turkey.

To test this hypothesis and to limit any confounding bias (latitude, etc.), we focused on the countries whose IL-6 gene polymorphisms at rs1800796 and rs1800795 loci, IL-6R gene polymorphism at rs2228145 locus, IL-10 gene polymorphism at rs1800896 and rs1800871 loci, IL-17A gene polymorphism at rs2275913 and IL-17F gene polymorphism at rs763780 loci were defined and the allele frequencies were reported in 54 studies. 10 Sweden, Poland, Germany, and the UK frequently have GC genotype.

Only the Japanese population frequently showed the CC genotype for rs1800796 polymorphism ( The analysis between the frequencies of rs1800796/rs1800795 polymorphism in IL-6 gene and rs2228145 polymorphism in IL-6R gene, and the prevalence of COVID-19 and mortality rates per country demonstrated that there was no significant correlation between the prevalence (per million), mortality rates (per million), and the frequencies of polymorphisms found in IL-6 and IL-6R genes (p > .05) ( Table 2) .

Population diversities of IL-10 gene polymorphisms at rs1800896 locus showed that the populations of China, Mexico, Tunisia, and Japan frequently have the AA genotype while the populations of India, Iran, Spain, Netherland, Finland, Brazil, Czechia, Poland, Germany, Norway, and the UK frequently have the AG genotype. The frequency of GG genotype of rs1800896 polymorphism was the highest only among the Italian population (- Table 3 ). Population diversities of IL-10 gene polymorphisms at rs1800871 locus showed that the populations of Spain, Italy, Finland, Czechia, Japan, Norway, and the UK frequently have CC genotype while the populations of India, Iran, Mexico, Netherland, Brazil, and Tunisia frequently have CT genotype. Only Chinese and German populations frequently showed TT genotype for rs1800871 polymorphism ( Table 3 ).

The analysis between the frequencies of rs1800896 and rs1800871 polymorphisms of IL-10 gene, and the prevalence of COVID-19 and mortality rates recorded on 7th September and 6th

December 2020 per country demonstrated that there was no significant correlation between the prevalence (per million), mortality rates (per million), and the frequencies of these polymorphisms found in IL-10 gene except the frequency of AG genotype at rs1800896 locus (Table 4 ). There was a statistically significant positive correlation between the frequency of AG genotype and the prevalence of COVID-19 cases recorded on 6th December 2020 (r: 0.53, r 2 : 0.28, p < .05). 28% of the variability among the number of cases may be explained by the frequency of AG genotype at rs1800896 among populations ( Figure S1 ). Table 5 ).

The analysis between the frequencies of rs2275913 polymorphism in IL-17A gene and prevalence of COVID-19 and mortality rates per country demonstrated that there was a significant negative correlation between the mortality rates (per million) recorded on 7th September 2020, and AG genotype (r: −0.51, r 2 :0.26, p < .05) while there was no significant correlation between the prevalence and mortality rates recorded on 6th

December 2020 and any genotype of the rs2275913 polymorphism ( Table 6 ). 26% of the variability among the mortality rates may be explained by the frequency of AG genotype at rs2275913 among the populations ( Figure S2 ).

The analysis between the frequencies of rs763780 polymorphism in IL-17F gene and the prevalence of COVID-19 cases and mortality rates per country demonstrated that there was a significant positive correlation between the prevalence (per million) recorded on 6th December 2020, and TT genotype (r: 0.65, r 2 : 0.42, p < .05) while a negative correlation was found between that prevalence and TC genotype (r: −0.66, r 2 : 0.43, p < .05). 42% and 43% of the variability among the number of cases may be explained by the frequency of TT and TC genotypes at rs763780, respectively ( Figure S3 ). Also, a significant negative correlation was found between the mortality rates (per million) recorded on 6th December T A B L E 2 Correlation between IL-6 (rs1800796/rs1800795) and IL-6R (rs2228145) polymorphisms and prevalence of COVID-19 and mortality rates for all countries Table 6 ). Therefore, 31% of the variability among the mortality rates may be explained by the frequency of CC genotypes at rs763780 locus among populations ( Figure S4 ).

In the present study, the AG genotype of rs1800896 locus in IL-10 which accounts for the high mortality rates. 64 In addition, the polymorphisms in the IL-6 gene were associated with specific viral infections including influenza virus, hepatitis C (HCV), and hepatitis B virus (HBV). 65 A very recent meta-analysis reported an association between a polymorphism in the IL-6 gene and predisposition and disease severity of pneumonia, suggested that the IL-6 allele carries a status of higher IL-6 production and pneumonia severity. 66 T A B L E 6 Correlation between IL-17A (rs2275913) and IL-17F (rs763780) polymorphisms and the prevalence of COVID-19 and mortality rates per country 

All authors have contributed significantly to the work.

COVID-19: pathogenesis, genetic polymorphism, clinical features and laboratory findings

World Health Organization. Coronavirus disease (COVID-19) Weekly epidemiological update

Clinical and immunological features of severe and moderate coronavirus disease 2019

Aberrant pathogenic GM-CSF+ T cells and inflammatory CD14+CD16+ monocytes in severe pulmonary syndrome patients of a new coronavirus

Characteristics of lymphocyte subsets and cytokines in peripheral blood of 123 hospitalized patients with 2019 novel coronavirus pneumonia (NCP)

Clinical features of patients infected with 2019 novel coronavirus in Wuhan

The role of host genetics in susceptibility to severe viral infections in humans and insights into host genetics of severe COVID-19: a systematic review

Association of IL-10 (−819T/C, −592A/C and −1082A/G) and IL-6 -174G/C gene polymorphism and the risk of pneumonia-induced sepsis

COVID-19: a case for inhibiting IL-17?

Determination of IL-1B (rs16944) and IL-6 (rs1800796) genetic polymorphisms in IgA nephropathy in a northwest Chinese Han population

Associations between polymorphisms of interleukin-6 and related cytokine genes and serum liver damage markers: a cross-sectional study in the Japan MultiInstitutional Collaborative Cohort (J-MICC) Study

Interleukin-6, interleukin-6 receptor gene variant, small-vessel disease and incident dementia

IL6/IL6R genetic diversity and plasma IL6 levels in bipolar disorder: An Indo-French study

No evidence of association between functional polymorphisms located within IL6R and IL6ST genes and Henoch-Schönlein purpura

IL-6 rs1800795 polymorphism is associated with septic shock-related death in patients who underwent major surgery: a preliminary retrospective study

Distribution of the IL-1RN, IL-6, IL-10, INF-γ, and TNFα gene polymorphisms in the Mexican population

Association of the IL6 rs1800796, but not of the IL6 rs1800795, IL6R rs4845617 and rs2228145 polymorphisms with hip fracture in elderly Mexican women

Functional polymorphisms within the inflammatory pathway regulate expression of extracellular matrix components in a genetic risk dependent model for anterior cruciate ligament injuries

Polymorphisms in the IL-6 and IL-6R receptor genes as new diagnostic biomarkers of acute appendicitis: a study on two candidate genes in pediatric patients with acute appendicitis

Influence of the 48867A>C (Asp358Ala) IL6R polymorphism on response to a lifestyle modification intervention in individuals with metabolic syndrome

Polymorphisms of interleukin 6 in Down syndrome individuals: a case-control study

IL6R Gene Polymorphic Variant rs2228145(C >A) as a marker of genetic liability to nonalcoholic steatohepatitis in the Russian population of Karelia

Association between interleukin-6/6R gene polymorphisms and coronary artery disease in Russian population: influence of interleukin-6/6R gene polymorphisms on inflammatory markers

Are IL1B, IL6 and IL6R gene variants associated with anterior cruciate ligament rupture susceptibility?

Association of TGFβ1 codon 10 (T>C) and IL-10 (G>C) cytokine gene polymorphisms with longevity in a cohort of Italian population

Sex-specific effects of CNTF, IL6 and UCP2 polymorphisms on weight gain

Association of the interleukin-6 rs1800795 polymorphism with type 2 diabetes mellitus in the population of the Island of Crete

Interleukin-6 promoter polymorphism (--174 G/C) in Caucasian German patients with systemic lupus erythematosus

The effect of novel polymorphisms in the interleukin-6 (IL-6) gene on IL-6 transcription and plasma IL-6 levels, and an association with systemic-onset juvenile chronic arthritis

Association of interleukin-10 polymorphisms (rs1800872, rs1800871, and rs1800896) with predisposition to IgA nephropathy in a Chinese Han population: a case-control study

Genetic variants of immune-related genes IL17F and IL10 are associated with functional dyspepsia: A case-control study

Interleukin 10 gene promoter polymorphisms (rs1800896, rs1800871 and rs1800872) and haplotypes are associated with the activity of systemic lupus erythematosus and IL10 levels in an Iranian population

Pro-and antiinflammatory cytokine gene single-nucleotide polymorphisms in inflammatory bowel disease

Polymorphisms in cytokine genes IL6, TNF, IL10, IL17A and IFNG influence susceptibility to complicated skin and skin structure infections

Association of IL10 promoter polymorphism in Italian Alzheimer's disease

Polymorphisms in the promoter region of IL10 gene are associated with virus etiology of infant bronchiolitis

Polymorphism in the interleukin-10 gene is associated with overactive bladder phenotype associated with HTLV-1 infection

Recurrent aphthous stomatitis and gene variability in selected interleukins: a casecontrol study

IL-10 gene promoter and intron polymorphisms as genetic biomarkers of cervical cancer susceptibility among Tunisians

Association of single nucleotide polymorphisms of the interleukin-10 promoter gene and susceptibility to primary biliary cirrhosis: immunogenetic differences in Italian and Japanese patients

Association of IL1A, IL1B, ILRN, IL6, IL10 and TNFα polymorphisms with risk and clinical course of multiple sclerosis in a Polish population

Association between a proinflammatory genetic profile and the risk of chronic atrophic gastritis among older adults from Germany

Interleukin-10 promoter polymorphisms in patients with multiple sclerosis

IL-10 genotype analysis in patients with Behçet's disease

Association of IL-17A and IL-17F gene polymorphisms with chronic hepatitis B and hepatitis B virusrelated liver cirrhosis in a Chinese population: A case-control study

IL17A and IL23R gene polymorphisms affect the clinical features and prognosis of patients with multiple myeloma

IL-17F sequence variant (His161Arg) is associated with protection against asthma and antagonizes wild-type IL-17F activity

Association of Interleukin-17 gene polymorphisms with susceptibility to chronic hepatitis B virus infection and clearance in Iranian population

The polymorphism rs763780 in the IL-17F gene is associated with response to biological drugs in patients with psoriasis

IL17A haplotype confers susceptibility to systemic lupus erythematosus but not to rheumatoid arthritis in Mexican patients

Lack of association of the polymorphisms IL-17A (-197G/A) and IL-17F (+7488A/G) with multibacillary leprosy in Mexican patients

Interleukin-6 and interleukin-17 gene polymorphism association with celiac disease in children

UCP2 (rs659366), and IL-17 (rs763780) gene variants in synthetic cannabinoid use disorder patients

Interleukin 17A gene polymorphism rs2275913 is associated with osteitis after the Bacillus Calmette-Guérin vaccination

Influence of TNF and IL17 Gene Ppolymorphisms on the spondyloarthritis immunopathogenesis, regardless of HLA-B27, in a Brazilian population

Genetic variation in key molecules of the Th-17 immune response is not associated with risk for prosthetic joint infection in a Czech population

Association of IL17 and IL23R gene polymorphisms with rheumatic heart disease in South Indian population

Genetic variation in TH17 pathway genes, childhood asthma, and total serum IgE levels

Association analysis of the interleukin 17A gene in Caucasian rheumatoid arthritis patients from Norway and New Zealand

IL-17A and IL17F genes variants and susceptibility to childhood asthma in Tunisia

IL-17F gene polymorphism is associated with susceptibility to acute myeloid leukemia

Interleukin-17A rs2275913, Interleukin-17F rs763780 and rs2397084 gene polymorphisms as possible risk factors in Juvenile lupus and lupus related nephritis

Interleukin-17 and Toll-like Receptor 10 genetic polymorphisms and susceptibility to large joint osteoarthritis

Cytokine release syndrome in severe COVID-19: interleukin-6 receptor antagonist tocilizumab may be the key to reduce mortality

Interleukin-6 gene variants are associated with reduced risk of chronicity in hepatitis B virus infection in a Malaysian population

Anti-IL-6 receptor antibody treatment for severe COVID-19 and the potential implication of IL-6 gene polymorphisms in novel coronavirus pneumonia. Tratamiento con anticuerpos anti-receptor de IL-6 para COVID-19 grave y la posible implicación de polimorfismos del gen IL-6 en la nueva neumonía por coronavirus

Clinical course and risk factors for mortality of adult inpatients with COVID-19 in Wuhan, China: a retrospective cohort study

The interferon gamma gene polymorphism +874 A/T is associated with severe acute respiratory syndrome

Association of cytokine and chemokine gene polymorphisms with severe acute respiratory syndrome

Clinical and biochemical indexes from 2019-nCoV infected patients linked to viral loads and lung injury

Correlations of IL-17 and NF-κB gene polymorphisms with susceptibility and prognosis in acute respiratory distress syndrome in a Chinese population

Interleukin-17A is associated with alveolar inflammation and poor outcomes in acute respiratory distress syndrome

Polymorphisms in the IL17 gene (rs2275913 and rs763780) are associated with hepatitis B virus infection in the Han Chinese population

The protective and pathogenic roles of IL-17 in viral infections: friend or foe?

Human TH17 cells lack HIV-inhibitory RNases and are highly permissive to productive HIV infection

Mucosal pre-exposure to Th17-inducing adjuvants exacerbates pathology after influenza infection

The authors declare that there are no conflict of interests.

The data that support the findings of this study are available from the corresponding author upon reasonable request.

http://orcid.org/0000-0002-4803-9137